Chronic Cough and Airway Remodelling in Refractory Cough Patients
Official title: Does Chronic Cough Lead to Injury and Remodelling of the Lower Airways?
Run by Medical University of Warsaw · NCT07659860 · Data updated 2026-11-12
This study tests whether long-lasting chronic cough damages and remodels the airways in adults who have had cough for over a year and have not responded to prior treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 4 sites (Warsaw, Masovian Voivodeship and 3 other locations) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | July 30, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT07659860 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with chronic cough for 12+ months, non-smokers, not on ACE inhibitors, no recent infections or smoking history, and with clinical indication for bronchoscopy.
✕Probably not a fit
Patients whose cough resolves or is not associated with structural airway changes may see no direct medical benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll up to 40 non-smoking adults with chronic cough lasting at least 12 months who are undergoing bronchoscopy for clinical indications. Researchers will analyze blood and bronchoalveolar lavage fluid for injury mediators, and use chest CT scans and bronchial tissue samples to assess airway remodelling and epithelial injury. The goal is to explore how cough duration and severity relate to inflammation, airway damage, and structural changes. Participants will undergo chest CT and bronchoscopy as part of standard clinical care, with data collected to characterize airway pathology associated with refractory cough.
Why it matters
Potential benefit: If successful, findings could improve understanding of airway changes in chronic cough and guide future therapies.
How similar studies have gone: Previous research has explored airway inflammation and remodeling in chronic respiratory diseases, but this study focuses on bronchial injury and remodelling specifically in refractory chronic cough.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria for the study group: 1. age between 18 and 75 years, 2. chronic cough of at least one year duration, with no previous treatment (at least 2 previous unsuccessful attempts at pharmacological treatment of cough) 3. negative history of smoking (at least 6 months of abstinence), 4. negative history of treatment with angiotensin-converting enzyme inhibitors (ACEI), 5. normal chest radiograph or with changes not relevant to cough formation, 6. no respiratory tract infections in the past 6 weeks, 7. written consent from the patient to participate in the study. Exclusion Criteria: 1. patients less than 18 and more than 75 years of age, 2. cough lasting less than 12 months, 3. active smoking or abstinence period of less than 6 months, 4. respiratory tract infection 6 weeks prior to inclusion or at the time of study conduct - retry inclusion after 6 weeks, 5. cancer or interstitial lung disease, 6. contraindications to functional testing, sputum induction or bronchoscopy
Where it's running
-
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland Recruiting -
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw
Warsaw, Warsaw, Poland Recruiting -
Medical University of Warsaw
Warsaw, Poland Recruiting -
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw
Warsaw, Poland Recruiting
Study contacts
- Study coordinator: Marta Dabrowska, MD, PhD
- Email: mdabrowska@mp.pl
- Phone: +48 501157765
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treatments for prolonged cough in children
It tests whether an inhaled steroid helps children with dry prolonged cough and whether an antibiotic helps children with wet prolonged cough compared with placebo.
-
Brief, breath-focused ACT for adults with chronic cough
This pilot test checks if a short, breath-control-oriented Acceptance and Commitment Therapy program is doable, acceptable, and safe for adults who have chronic cough.
-
Behavioral therapy for persistent chronic cough
This program will try behavioral cough suppression therapy to help adults whose cough has lasted more than eight weeks and has not improved with usual treatments.
-
Biomarkers and Respiratory Omics in Children: Predicting Disease Course
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
-
Evaluating treatment satisfaction with gefapixant for chronic cough
This study is testing how satisfied adults with stubborn chronic cough are with the treatment gefapixant and whether any taste changes they experience affect their quality of life related to coughing.
-
Observing cough patterns in patients with chronic cough
This study is trying to understand different types of coughs in people with chronic cough by using a new questionnaire to see how often they cough and how it affects their daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.